The Latest Breaking News from Moderna

Photos of the week: Congress returned to Washington for a shortened work week this week.

WASHINGTON — Moderna CEO Stéphane Bancel attempted on Wednesday to win over lawmakers irate about the company’s planned COVID-19 vaccine price increase, weathering a barrage of criticism from Democrats angry at the company’s profits from its groundbreaking mRNA vaccine.

Moderna CEO Stephane Bancel will face off with Sen. Bernie Sanders on Wednesday over the Covid shot. The battle could rock Moderna stock.

WASHINGTON — Moderna Inc. plans to tell U.S. lawmakers that it more than adequately compensated the government for its role in a COVID-19 vaccine partnership that brought the drugmaker billions of dollars, a central point in what’s likely to be a heated Capitol Hill hearing this week.

As new chairman of the Senate HELP Committee, Sanders maps out his strategy for negotiating with GOP and Big Pharma

Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

A shot against mpox would be valuable in case outbreaks reemerge, and the company sees bird flu as a “clear threat,” the company's president said.